Srijanani Santhanakrishnan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Srijanani Santhanakrishnan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ashwini Deshpande
Department of Research, Meenakshi Academy of Higher Education and Research, Chennai, India
1 shared publication - Chandrasekaran Krithika
Meenakshi Academy of Higher Education and Research
1 shared publication - Sankar Leena Sankari
Department of Oral and Maxillofacial Pathology and Oral Microbiology, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Chennai 600100, India
1 shared publication - Selvaraj Jayaraman
Department of Biochemistry, Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India
1 shared publication - Sridhar Chitathoor
Internal Medicine, Meenakshi Academy of Higher Education and Research, Chennai, India
1 shared publication
Latest Publications
- Open Access
- 26 October 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Oral Cavity Involvement in Mucormycosis: A Systematic Review
Background: Mucormycosis is a rare but life-threatening fungal infection. While rhinocerebral forms are well-documented, oral cavity involvement remains underreported and misdiagnosed, despite its potential for rapid progression and serious complications. Aim: This systematic review aimed to evaluate and synthesize available evidence on the clinical presentation, anatomical patterns, diagnostic methods, outcomes, and management strategies associated with oral cavity involvement in mucormycosis. Methodology: Literature search was conducted across PubMed, Scopus, Embase, Web of Science, and Google Scholar up to 2025. Eligible human studies were included. Data were extracted and narratively synthesized. Quality assessment was conducted using the Newcastle-Ottawa Scale, and risk of bias was evaluated with the ROBINS-I tool with 7 included studies. Results: Seven studies comprising 451 cases were analyzed. Most patients were middle-aged males with diabetes and a recent post-COVID-19 status. Common clinical features included palatal ulcers, eschar, tooth mobility, and necrotic lesions. Diagnosis relied on potassium hydroxide mount, histopathology, and imaging. Amphotericin B was the mainstay of antifungal therapy, often combined with surgical debridement or maxillectomy. Mortality varied widely across studies, with better outcomes linked to early diagnosis and combined treatment. Conclusion: Oral Mucormycosis is a critical yet often underrecognized condition. Timely identification in high-risk patients is essential to prevent progression.
- 26 October 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessOral Cavity Involvement in Mucormycosis: A Systematic Review
Background: Mucormycosis is a rare but life-threatening fungal infection. While rhinocerebral forms are well-documented, oral cavity involvement remains underreported and misdiagnosed, despite its potential for rapid progression and serious complications. Aim: This systematic review aimed to evaluate and synthesize available evidence on the clinical presentation, anatomical patterns, diagnostic methods, outcomes, and management strategies associated with oral cavity involvement in mucormycosis. Methodology: Literature search was conducted across PubMed, Scopus, Embase, Web of Science, and Google Scholar up to 2025. Eligible human studies were included. Data were extracted and narratively synthesized. Quality assessment was conducted using the Newcastle-Ottawa Scale, and risk of bias was evaluated with the ROBINS-I tool with 7 included studies. Results: Seven studies comprising 451 cases were analyzed. Most patients were middle-aged males with diabetes and a recent post-COVID-19 status. Common clinical features included palatal ulcers, eschar, tooth mobility, and necrotic lesions. Diagnosis relied on potassium hydroxide mount, histopathology, and imaging. Amphotericin B was the mainstay of antifungal therapy, often combined with surgical debridement or maxillectomy. Mortality varied widely across studies, with better outcomes linked to early diagnosis and combined treatment. Conclusion: Oral Mucormycosis is a critical yet often underrecognized condition. Timely identification in high-risk patients is essential to prevent progression.